(Q40918214)

24 September 2017

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial (English)

1 reference

24 September 2017

1 reference

C E Atterbury

1

1 reference

PubMed ID

354373

24 September 2017

W C Maddrey

series ordinal

2

1 reference

PubMed ID

354373

24 September 2017

H O Conn

series ordinal

3

1 reference

24 September 2017

1 May 1978

1 reference

The American journal of digestive diseases

24 September 2017

1 reference

24 September 2017

23

1 reference

24 September 2017

398-406

1 reference

24 September 2017

5

1 reference

A controlled clinical trial of lactulose in hepatic encephalopathy

24 September 2017

1 reference

12 December 2020

Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature

1 reference

12 December 2020

Lactulose in the treatment of acute hepatic encephalopathy

1 reference

12 December 2020

Dilemmas of clinical experimentation: use of lactulose in portocaval encephalopathy

1 reference

12 December 2020

Comparative study of basal arterial ammonemia and of orally-induced hyperammonemia in chronic portal systemic encephalopathy, treated with neomycin, lactulose, and an association of neomycin and lactulose.

1 reference

12 December 2020

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

1 reference

12 December 2020

Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt

1 reference

12 December 2020

[Value of lactulose in the treatment of chronic porto-cave encephalopathy (20 cases)]

1 reference

12 December 2020

Comparison of results of long-term treatment of chronic hepatic encephalopathy with lactulose and sorbitol

1 reference

12 December 2020

[Lactulose in the treatment of chronic portosystemic encephalopathies]

1 reference

12 December 2020

Cirrhosis, hyperammonemia and Lactulose

1 reference

12 December 2020

Preliminary study of the use of lactulose (1,4-beta-galactoside-fructose) in the long-term treatment of portal systemic encephalopathy

1 reference

12 December 2020

The measurement of ammonia in whole blood, erythrocytes, and plasma

1 reference

12 December 2020

Faecal ammonia and pH during lactulose administration in man: comparison with other cathartics

1 reference

12 December 2020

Treatment of chronic hepatic encephalopathy with lactulose

1 reference

12 December 2020

Long-term treatment of portal-systemic encephalopathy with lactulose

1 reference

12 December 2020

Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy

1 reference

12 December 2020

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial

1 reference

12 December 2020

Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01072921

1 reference

24 September 2017

1 reference

PubMed ID

354373